A highly accomplished thought leader in global regulatory sciences with over 30 years of experience with leading biopharmaceutical companies spanning all phases of drug development. Recognized as an industry expert in global drug development, focusing on innovative regulatory strategies that facilitate accelerated regulatory reviews and approvals.

Highly effective in bridging the interfaces between discovery, development, manufacturing, medical, and commercial to accelerate the introduction of new medicines addressing unmet patient needs. Expert in applying AI/ML to predicting regulatory outcomes, and advancing AI/ML policies, and is the human-in/on-the loop as an SME in global drug development and regulatory sciences.